Loading insider details...
Latest Form 4 (Aug 6, 2026): Grant/Award of 162,311 SPRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 162,311 | n/a |
| Mar 2, 2022 | EXAGEN INC. (XGN) | Tax Withholding | 3,241 | $23.1K |
| Feb 8, 2022 | EXAGEN INC. (XGN) | Grant/Award | 50,000 | n/a |
| Feb 25, 2021 | EXAGEN INC. (XGN) | Grant/Award | 37,500 | n/a |
| Mar 26, 2020 | EXAGEN INC. (XGN) | Grant/Award | 100,000 | n/a |